ONTOLOGY REPORT - ANNOTATIONS
| Term: | carbon group element atom |
|
| Accession: | CHEBI:33306
|
browse the term
|
| Synonyms: | exact_synonym: | group 14 elements |
| | related_synonym: | carbon group element; carbon group elements; carbonoides; cristallogene; cristallogenes; group IV elements |
|
|
lead diacetate
|
| G |
A2m |
alpha-2-macroglobulin |
|
affects expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Aars |
alanyl-tRNA synthetase |
|
increases expression |
EXP |
19 |
40,952,408 |
40,974,425 |
RGD:6480464 |
CTD |
| G |
Abce1 |
ATP-binding cassette, subfamily E (OABP), member 1 |
|
increases expression |
EXP |
19 |
30,093,741 |
30,118,625 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
decreases expression |
ISO |
8 |
57,044,478 |
57,072,970 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
affects expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
|
decreases expression |
ISO |
15 |
32,719,863 |
32,764,748 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
increases expression |
ISO |
5 |
169,409,306 |
169,501,907 |
RGD:6480464 |
CTD |
| G |
Acpl2 |
acid phosphatase-like 2 |
|
increases expression |
ISO |
8 |
101,917,842 |
101,983,158 |
RGD:6480464 |
CTD |
| G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
|
affects expression |
EXP |
1 |
178,054,386 |
178,081,751 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
affects expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Acyp2 |
acylphosphatase 2, muscle type |
|
decreases expression |
ISO |
14 |
111,507,725 |
111,512,680 |
RGD:6480464 |
CTD |
| G |
Acyp2 |
acylphosphatase 2, muscle type |
|
decreases expression |
ISO |
14 |
111,507,725 |
111,512,680 |
RGD:6480464 |
CTD |
| G |
Acyp2-ps1 |
acylphosphatase 2, muscle type, pseudogene 1 |
|
decreases expression |
ISO |
14 |
111,836,252 |
111,836,724 |
RGD:6480464 |
CTD |
| G |
Adamtsl1 |
ADAMTS-like 1 |
|
increases expression |
ISO |
5 |
105,037,301 |
105,423,414 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
increases expression |
ISO |
7 |
101,957,807 |
102,210,346 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
increases expression |
EXP |
7 |
101,957,807 |
102,210,346 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases expression |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adk |
adenosine kinase |
|
decreases expression |
ISO |
15 |
3,071,412 |
3,458,891 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
increases expression |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
increases expression |
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Agpat6 |
1-acylglycerol-3-phosphate O-acyltransferase 6 |
|
increases expression |
ISO |
16 |
73,276,423 |
73,310,177 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
increases expression |
ISO |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Aif1 |
allograft inflammatory factor 1 |
|
increases expression |
ISO |
20 |
3,714,428 |
3,716,327 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects expression |
EXP |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
increases expression |
ISO |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
|
increases expression |
ISO |
18 |
52,300,899 |
52,333,149 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
decreases expression |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Amy1a |
amylase, alpha 1A (salivary) |
|
decreases activity |
EXP |
2 |
209,548,721 |
209,563,532 |
RGD:6480464 |
CTD |
| G |
Ankrd24 |
ankyrin repeat domain 24 |
|
decreases expression |
ISO |
7 |
9,534,366 |
9,554,062 |
RGD:6480464 |
CTD |
| G |
Antxr2 |
anthrax toxin receptor 2 |
|
decreases expression |
ISO |
14 |
12,875,632 |
13,107,975 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
decreases expression |
EXP |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
decreases methylation |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
decreases activity |
EXP |
19 |
52,854,657 |
52,856,625 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
decreases activity |
ISO |
19 |
52,854,657 |
52,856,625 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
|
decreases expression |
ISO |
3 |
75,620,198 |
75,633,343 |
RGD:6480464 |
CTD |
| G |
Arfgef2 |
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) |
|
decreases expression |
ISO |
3 |
157,967,942 |
158,051,359 |
RGD:6480464 |
CTD |
| G |
Arglu1 |
arginine and glutamate rich 1 |
|
increases expression |
ISO |
16 |
86,143,399 |
86,181,601 |
RGD:6480464 |
CTD |
| G |
Arhgap17 |
Rho GTPase activating protein 17 |
|
decreases expression |
ISO |
1 |
182,145,313 |
182,234,995 |
RGD:6480464 |
CTD |
| G |
Arhgap24 |
Rho GTPase activating protein 24 |
|
increases expression |
ISO |
14 |
8,026,238 |
8,075,033 |
RGD:6480464 |
CTD |
| G |
Arl1 |
ADP-ribosylation factor-like 1 |
|
decreases expression |
ISO |
7 |
25,403,921 |
25,416,168 |
RGD:6480464 |
CTD |
| G |
Arl8b |
ADP-ribosylation factor-like 8B |
|
increases expression |
ISO |
4 |
144,299,366 |
144,344,431 |
RGD:6480464 |
CTD |
| G |
Arpp21 |
cAMP-regulated phosphoprotein 21 |
|
decreases expression |
ISO |
8 |
116,674,803 |
116,794,799 |
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
increases expression |
ISO |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
increases expression |
EXP |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
EXP |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
decreases expression |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
EXP |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
affects expression |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
increases expression |
EXP |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp6v1e1 |
ATPase, H+ transporting, lysosomal V1 subunit E1 |
|
increases expression |
ISO |
4 |
157,203,842 |
157,225,966 |
RGD:6480464 |
CTD |
| G |
Atp7a |
ATPase, Cu++ transporting, alpha polypeptide |
|
multiple interactions |
EXP |
X |
94,192,540 |
94,249,776 |
RGD:6480464 |
CTD |
| G |
Atp9b |
ATPase, class II, type 9B |
|
increases expression |
ISO |
18 |
77,616,788 |
77,812,509 |
RGD:6480464 |
CTD |
| G |
Atxn1 |
ataxin 1 |
|
decreases expression |
EXP |
17 |
24,719,383 |
25,138,270 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
affects expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
multiple interactions |
ISO |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcat1 |
branched chain amino acid transaminase 1, cytosolic |
|
increases expression |
EXP |
4 |
182,641,517 |
182,692,917 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bdh2 |
3-hydroxybutyrate dehydrogenase, type 2 |
|
increases expression |
ISO |
2 |
232,765,049 |
232,785,694 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases response to substance |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases secretion |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
affects expression |
EXP |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases activity |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bpifb3 |
BPI fold containing family B, member 3 |
|
increases expression |
ISO |
3 |
144,303,258 |
144,317,875 |
RGD:6480464 |
CTD |
| G |
Bri3 |
brain protein I3 |
|
decreases expression |
ISO |
12 |
10,670,023 |
10,678,698 |
RGD:6480464 |
CTD |
| G |
Btbd7 |
BTB (POZ) domain containing 7 |
|
decreases expression |
ISO |
6 |
127,056,657 |
127,105,458 |
RGD:6480464 |
CTD |
| G |
Btbd9 |
BTB (POZ) domain containing 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Btla |
B and T lymphocyte associated |
|
increases expression |
ISO |
11 |
57,102,004 |
57,123,067 |
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
increases expression |
ISO |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
Cald1 |
caldesmon 1 |
|
decreases expression |
EXP |
4 |
62,087,364 |
62,156,855 |
RGD:6480464 |
CTD |
| G |
Calml3 |
calmodulin-like 3 |
|
increases expression |
EXP |
17 |
77,594,514 |
77,595,889 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
decreases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
ISO |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Camk2n2 |
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
|
decreases expression |
ISO |
11 |
82,519,331 |
82,519,584 |
RGD:6480464 |
CTD |
| G |
Car11 |
carbonic anhydrase 11 |
|
increases expression |
ISO |
1 |
96,167,823 |
96,172,934 |
RGD:6480464 |
CTD |
| G |
Car14 |
carbonic anhydrase 14 |
|
affects expression |
EXP |
2 |
190,683,916 |
190,690,229 |
RGD:6480464 |
CTD |
| G |
Cars |
cysteinyl-tRNA synthetase |
|
increases expression |
EXP |
1 |
203,934,812 |
203,977,042 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cbl |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
8 |
47,135,357 |
47,211,889 |
RGD:6480464 |
CTD |
| G |
Cbl |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
|
increases phosphorylation |
EXP |
8 |
47,135,357 |
47,211,889 |
RGD:6480464 |
CTD |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
decreases expression |
ISO |
11 |
49,690,402 |
49,856,762 |
RGD:6480464 |
CTD |
| G |
Cbx1 |
chromobox homolog 1 |
|
decreases expression |
ISO |
10 |
85,544,537 |
85,564,903 |
RGD:6480464 |
CTD |
| G |
Ccdc117 |
coiled-coil domain containing 117 |
|
decreases expression |
ISO |
14 |
86,161,551 |
86,170,917 |
RGD:6480464 |
CTD |
| G |
Ccdc80 |
coiled-coil domain containing 80 |
|
decreases expression |
ISO |
11 |
57,222,551 |
57,257,162 |
RGD:6480464 |
CTD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
increases expression |
ISO |
10 |
70,380,498 |
70,383,276 |
RGD:6480464 |
CTD |
| G |
Ccl12 |
chemokine (C-C motif) ligand 12 |
|
increases expression |
ISO |
10 |
70,321,036 |
70,322,586 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccr4 |
chemokine (C-C motif) receptor 4 |
|
increases expression |
ISO |
8 |
118,883,148 |
118,884,230 |
RGD:6480464 |
CTD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
decreases expression |
ISO |
10 |
87,925,093 |
87,936,325 |
RGD:6480464 |
CTD |
| G |
Cd209f |
CD209f antigen |
|
increases expression |
ISO |
12 |
1,657,463 |
1,660,482 |
RGD:6480464 |
CTD |
| G |
Cd247 |
Cd247 molecule |
|
increases expression |
ISO |
13 |
81,515,383 |
81,594,699 |
RGD:6480464 |
CTD |
| G |
Cd27 |
CD27 molecule |
|
decreases expression |
ISO |
4 |
161,351,797 |
161,356,688 |
RGD:6480464 |
CTD |
| G |
Cd27 |
CD27 molecule |
|
increases expression |
ISO |
4 |
161,351,797 |
161,356,688 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd47 |
Cd47 molecule |
|
decreases expression |
ISO |
11 |
52,098,355 |
52,158,169 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
increases mutagenesis |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
increases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdc45 |
cell division cycle 45 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
increases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
EXP |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
increases expression |
ISO |
17 |
41,208,037 |
41,259,863 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdr2 |
cerebellar degeneration-related 2 |
|
affects expression |
EXP |
1 |
179,804,350 |
179,829,258 |
RGD:6480464 |
CTD |
| G |
Cds2 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 |
|
increases expression |
ISO |
3 |
120,025,455 |
120,063,992 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
increases expression |
ISO |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Cela3b |
chymotrypsin-like elastase family, member 3B |
|
increases expression |
ISO |
5 |
156,178,728 |
156,186,891 |
RGD:6480464 |
CTD |
| G |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
|
increases expression |
ISO |
1 |
201,614,373 |
201,617,370 |
RGD:6480464 |
CTD |
| G |
Cenpe |
centromere protein E |
|
increases expression |
EXP |
2 |
232,699,627 |
232,758,329 |
RGD:6480464 |
CTD |
| G |
Cenpv |
centromere protein V |
|
decreases expression |
ISO |
10 |
48,705,067 |
48,718,758 |
RGD:6480464 |
CTD |
| G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
|
decreases expression |
ISO |
2 |
201,801,921 |
201,843,259 |
RGD:6480464 |
CTD |
| G |
Cfp |
complement factor properdin |
|
increases expression |
ISO |
X |
12,584,709 |
12,590,271 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
decreases activity |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Chd3 |
chromodomain helicase DNA binding protein 3 |
|
decreases expression |
ISO |
10 |
56,135,930 |
56,166,645 |
RGD:6480464 |
CTD |
| G |
Chid1 |
chitinase domain containing 1 |
|
increases expression |
ISO |
1 |
201,683,719 |
201,718,785 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
decreases expression |
EXP |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
|
increases expression |
ISO |
19 |
10,619,171 |
10,632,187 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
affects expression |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
multiple interactions |
ISO |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
increases expression |
EXP |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
multiple interactions |
EXP |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
|
increases expression |
EXP |
16 |
32,447,259 |
32,518,533 |
RGD:6480464 |
CTD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
increases expression |
EXP |
10 |
14,379,803 |
14,403,898 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
affects expression |
EXP |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn19 |
claudin 19 |
|
affects expression |
EXP |
5 |
139,838,014 |
139,842,711 |
RGD:6480464 |
CTD |
| G |
Clic6 |
chloride intracellular channel 6 |
|
affects expression |
EXP |
11 |
32,516,492 |
32,559,195 |
RGD:6480464 |
CTD |
| G |
Cndp2 |
CNDP dipeptidase 2 (metallopeptidase M20 family) |
|
increases expression |
ISO |
18 |
81,215,851 |
81,232,949 |
RGD:6480464 |
CTD |
| G |
Cnnm3 |
cyclin M3 |
|
decreases expression |
ISO |
9 |
35,454,856 |
35,470,211 |
RGD:6480464 |
CTD |
| G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
decreases expression |
ISO |
10 |
89,519,421 |
89,525,978 |
RGD:6480464 |
CTD |
| G |
Cntnap2 |
contactin associated protein-like 2 |
|
decreases expression |
ISO |
4 |
74,277,978 |
75,440,178 |
RGD:6480464 |
CTD |
| G |
Cog8 |
component of oligomeric golgi complex 8 |
|
decreases expression |
ISO |
19 |
36,904,222 |
36,914,972 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
decreases expression |
EXP |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col13a1 |
collagen, type XIII, alpha 1 |
|
decreases expression |
EXP |
20 |
29,208,654 |
29,348,751 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
decreases expression |
EXP |
5 |
63,825,907 |
63,930,633 |
RGD:6480464 |
CTD |
| G |
Col16a1 |
collagen, type XVI, alpha 1 |
|
decreases expression |
EXP |
5 |
149,072,905 |
149,126,350 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
EXP |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col19a1 |
collagen, type XIX, alpha 1 |
|
decreases expression |
EXP |
9 |
23,003,618 |
23,337,800 |
RGD:6480464 |
CTD |
| G |
Col19a1 |
collagen, type XIX, alpha 1 |
|
increases expression |
ISO |
9 |
23,003,618 |
23,337,800 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
decreases expression |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
decreases expression |
EXP |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a4 |
collagen, type IV, alpha 4 |
|
decreases expression |
EXP |
9 |
81,866,835 |
81,910,088 |
RGD:6480464 |
CTD |
| G |
Col4a5 |
collagen, type IV, alpha 5 |
|
decreases expression |
EXP |
X |
36,918,697 |
37,130,659 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
decreases expression |
EXP |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
increases expression |
EXP |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a2 |
collagen, type VI, alpha 2 |
|
multiple interactions |
ISO |
20 |
12,436,783 |
12,464,512 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
increases expression |
EXP |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
decreases expression |
EXP |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Col9a1 |
collagen, type IX, alpha 1 |
|
decreases expression |
EXP |
9 |
22,907,157 |
22,990,836 |
RGD:6480464 |
CTD |
| G |
Colgalt1 |
collagen beta(1-O)galactosyltransferase 1 |
|
increases expression |
ISO |
16 |
18,810,962 |
18,823,237 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1 (pancreatic) |
|
increases expression |
ISO |
4 |
57,549,260 |
57,555,361 |
RGD:6480464 |
CTD |
| G |
Cpa2 |
carboxypeptidase A2 (pancreatic) |
|
increases expression |
ISO |
4 |
57,452,111 |
57,475,357 |
RGD:6480464 |
CTD |
| G |
Cpb1 |
carboxypeptidase B1 (tissue) |
|
increases expression |
ISO |
2 |
105,413,336 |
105,443,909 |
RGD:6480464 |
CTD |
| G |
Cpsf3 |
cleavage and polyadenylation specific factor 3, 73kDa |
|
decreases expression |
ISO |
6 |
41,844,971 |
41,873,619 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
decreases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
affects expression |
ISO |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Crnkl1 |
crooked neck pre-mRNA splicing factor-like 1 (Drosophila) |
|
decreases expression |
ISO |
3 |
134,538,940 |
134,554,660 |
RGD:6480464 |
CTD |
| G |
Crnkl1-ps1 |
crooked neck pre-mRNA splicing factor-like 1 (Drosophila) pseudogene |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
increases secretion |
EXP |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
multiple interactions |
EXP |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
decreases expression |
ISO |
15 |
36,320,075 |
36,440,579 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
affects expression |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Ctr9 |
Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
1 |
168,784,355 |
168,814,971 |
RGD:6480464 |
CTD |
| G |
Ctrc |
chymotrypsin C (caldecrin) |
|
increases expression |
ISO |
5 |
160,742,491 |
160,755,332 |
RGD:6480464 |
CTD |
| G |
Ctrl |
chymotrypsin-like |
|
increases expression |
ISO |
19 |
35,774,031 |
35,775,881 |
RGD:6480464 |
CTD |
| G |
Ctsa |
cathepsin A |
|
increases expression |
ISO |
3 |
155,866,335 |
155,871,998 |
RGD:6480464 |
CTD |
| G |
Ctsa |
cathepsin A |
|
increases expression |
EXP |
3 |
155,866,335 |
155,871,998 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Cttn |
cortactin |
|
decreases expression |
ISO |
1 |
204,865,768 |
204,901,221 |
RGD:6480464 |
CTD |
| G |
Cuzd1 |
CUB and zona pellucida-like domains 1 |
|
increases expression |
ISO |
1 |
190,887,527 |
190,900,654 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
increases secretion |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
increases expression |
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
affects expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyb5b |
cytochrome b5 type B (outer mitochondrial membrane) |
|
increases expression |
ISO |
19 |
37,016,959 |
37,050,722 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
affects expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
9 |
74,039,204 |
74,068,648 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Dao |
D-amino-acid oxidase |
|
increases expression |
EXP |
12 |
43,627,593 |
43,648,332 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
increases expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapl1 |
death associated protein-like 1 |
|
decreases expression |
ISO |
3 |
41,187,967 |
41,207,910 |
RGD:6480464 |
CTD |
| G |
Dars |
aspartyl-tRNA synthetase |
|
increases expression |
EXP |
13 |
41,077,395 |
41,132,513 |
RGD:6480464 |
CTD |
| G |
Dbf4 |
DBF4 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
22,522,387 |
22,547,180 |
RGD:6480464 |
CTD |
| G |
Dbn1 |
drebrin 1 |
|
increases expression |
EXP |
17 |
15,194,687 |
15,208,660 |
RGD:6480464 |
CTD |
| G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
|
increases expression |
ISO |
7 |
75,318,788 |
75,336,382 |
RGD:6480464 |
CTD |
| G |
Dctn3 |
dynactin 3 |
|
increases expression |
ISO |
5 |
59,139,424 |
59,147,420 |
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
increases expression |
ISO |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
increases expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddx39a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
affects expression |
ISO |
19 |
26,109,094 |
26,117,042 |
RGD:6480464 |
CTD |
| G |
Ddx39b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
|
decreases expression |
ISO |
20 |
3,611,128 |
3,623,578 |
RGD:6480464 |
CTD |
| G |
Denr |
density-regulated protein |
|
increases expression |
ISO |
12 |
33,797,483 |
33,819,744 |
RGD:6480464 |
CTD |
| G |
Dgcr8 |
DiGeorge syndrome critical region gene 8 |
|
decreases expression |
EXP |
11 |
84,698,795 |
84,731,041 |
RGD:6480464 |
CTD |
| G |
Dgka |
diacylglycerol kinase, alpha |
|
increases expression |
EXP |
7 |
2,018,858 |
2,045,336 |
RGD:6480464 |
CTD |
| G |
Diaph2 |
diaphanous homolog 2 (Drosophila) |
|
increases expression |
ISO |
X |
116,641,770 |
117,258,314 |
RGD:6480464 |
CTD |
| G |
Disc1 |
disrupted in schizophrenia 1 |
|
increases expression |
EXP |
19 |
55,265,116 |
55,449,375 |
RGD:6480464 |
CTD |
| G |
Dleu7 |
deleted in lymphocytic leukemia, 7 |
|
increases expression |
ISO |
15 |
41,493,066 |
41,509,220 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
increases expression |
ISO |
1 |
190,378,428 |
190,470,536 |
RGD:6480464 |
CTD |
| G |
Dmrt2 |
doublesex and mab-3 related transcription factor 2 |
|
decreases expression |
ISO |
1 |
229,114,066 |
229,120,555 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajc21 |
DnaJ (Hsp40) homolog, subfamily C, member 21 |
|
decreases expression |
ISO |
2 |
59,796,394 |
59,814,160 |
RGD:6480464 |
CTD |
| G |
Dnase2 |
deoxyribonuclease II, lysosomal |
|
decreases expression |
ISO |
19 |
24,900,949 |
24,903,617 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
EXP |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnpep |
aspartyl aminopeptidase |
|
increases expression |
ISO |
9 |
74,586,544 |
74,595,414 |
RGD:6480464 |
CTD |
| G |
Dock1 |
dedicator of cyto-kinesis 1 |
|
increases expression |
ISO |
1 |
194,172,914 |
194,795,629 |
RGD:6480464 |
CTD |
| G |
Dok2 |
docking protein 2 |
|
affects expression |
ISO |
15 |
51,171,277 |
51,174,337 |
RGD:6480464 |
CTD |
| G |
Dok3 |
docking protein 3 |
|
increases expression |
ISO |
17 |
15,154,414 |
15,159,609 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
increases expression |
ISO |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp16 |
dual specificity phosphatase 16 |
|
decreases expression |
ISO |
4 |
171,620,395 |
171,667,593 |
RGD:6480464 |
CTD |
| G |
Dusp23 |
dual specificity phosphatase 23 |
|
increases expression |
ISO |
13 |
88,637,671 |
88,638,863 |
RGD:6480464 |
CTD |
| G |
Efcab1 |
EF hand calcium binding domain 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
decreases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Eif1a |
eukaryotic translation initiation factor 1A |
|
decreases expression |
ISO |
18 |
40,808,057 |
40,819,421 |
RGD:6480464 |
CTD |
| G |
Eif1a |
eukaryotic translation initiation factor 1A |
|
decreases expression |
ISO |
18 |
40,808,057 |
40,819,421 |
RGD:6480464 |
CTD |
| G |
Eif1ax |
eukaryotic translation initiation factor 1A, X-linked |
|
decreases expression |
ISO |
X |
56,700,148 |
56,714,851 |
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
|
decreases expression |
ISO |
10 |
56,484,232 |
56,489,739 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
increases expression |
ISO |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Emg1 |
EMG1 nucleolar protein homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
160,826,925 |
160,835,206 |
RGD:6480464 |
CTD |
| G |
Emr4 |
EGF-like module containing, mucin-like, hormone receptor-like sequence 4 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
increases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
increases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
increases expression |
ISO |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
decreases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
|
increases expression |
ISO |
6 |
108,439,822 |
108,469,756 |
RGD:6480464 |
CTD |
| G |
Entpd8 |
ectonucleoside triphosphate diphosphohydrolase 8 |
|
increases expression |
ISO |
3 |
5,229,747 |
5,258,064 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
multiple interactions |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
increases expression |
EXP |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Epha5 |
EPH receptor A5 |
|
multiple interactions |
ISO |
14 |
25,524,170 |
25,896,798 |
RGD:6480464 |
CTD |
| G |
Ephb1 |
Eph receptor B1 |
|
increases expression |
ISO |
8 |
106,871,856 |
107,328,156 |
RGD:6480464 |
CTD |
| G |
Ephb3 |
Eph receptor B3 |
|
decreases expression |
EXP |
11 |
82,027,632 |
82,046,332 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
affects expression |
EXP |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
|
increases expression |
EXP |
13 |
101,375,656 |
101,448,175 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
multiple interactions |
ISO |
7 |
1,858,057 |
1,877,353 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
increases expression |
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
increases expression |
ISO |
1 |
93,820,124 |
93,834,288 |
RGD:6480464 |
CTD |
| G |
Evl |
Enah/Vasp-like |
|
increases expression |
EXP |
6 |
132,952,804 |
133,019,870 |
RGD:6480464 |
CTD |
| G |
Fa2h |
fatty acid 2-hydroxylase |
|
increases expression |
ISO |
19 |
41,268,120 |
41,319,682 |
RGD:6480464 |
CTD |
| G |
Fam73b |
family with sequence similarity 73, member B |
|
increases expression |
ISO |
3 |
9,408,140 |
9,430,785 |
RGD:6480464 |
CTD |
| G |
Fan1 |
FANCD2/FANCI-associated nuclease 1 |
|
increases expression |
ISO |
1 |
118,784,938 |
118,811,928 |
RGD:6480464 |
CTD |
| G |
Farsa |
phenylalanyl-tRNA synthetase, alpha subunit |
|
decreases expression |
EXP |
19 |
24,947,663 |
24,957,186 |
RGD:6480464 |
CTD |
| G |
Fat1 |
FAT tumor suppressor homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
16 |
50,472,074 |
50,591,399 |
RGD:6480464 |
CTD |
| G |
Fbl |
fibrillarin |
|
affects localization |
ISO |
1 |
83,271,967 |
83,281,069 |
RGD:6480464 |
CTD |
| G |
Fbn1 |
fibrillin 1 |
|
increases expression |
ISO |
3 |
112,608,480 |
112,804,118 |
RGD:6480464 |
CTD |
| G |
Fbxl6 |
F-box and leucine-rich repeat protein 6 |
|
decreases expression |
ISO |
7 |
114,587,758 |
114,590,656 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
increases expression |
ISO |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fbxo33 |
F-box protein 33 |
|
increases expression |
ISO |
6 |
79,902,508 |
79,934,591 |
RGD:6480464 |
CTD |
| G |
Fcer2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
|
increases expression |
ISO |
12 |
2,444,054 |
2,469,678 |
RGD:6480464 |
CTD |
| G |
Fcgr3a |
Fc fragment of IgG, low affinity IIIa, receptor |
|
decreases expression |
ISO |
13 |
86,867,641 |
86,877,665 |
RGD:6480464 |
CTD |
| G |
Fcgrt |
Fc fragment of IgG, receptor, transporter, alpha |
|
decreases expression |
ISO |
1 |
95,566,717 |
95,575,645 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
affects expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Flt4 |
fms-related tyrosine kinase 4 |
|
increases expression |
EXP |
10 |
35,071,002 |
35,112,006 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
affects expression |
EXP |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
increases expression |
ISO |
X |
26,950,006 |
26,965,329 |
RGD:6480464 |
CTD |
| G |
Frem2 |
Fras1 related extracellular matrix protein 2 |
|
increases expression |
ISO |
2 |
142,464,169 |
142,604,059 |
RGD:6480464 |
CTD |
| G |
Frk |
fyn-related kinase |
|
increases expression |
EXP |
20 |
38,882,048 |
38,909,179 |
RGD:6480464 |
CTD |
| G |
Fry |
furry homolog (Drosophila) |
|
increases expression |
ISO |
12 |
4,886,882 |
5,135,963 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
EXP |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
EXP |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
increases activity |
EXP |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Gaa |
glucosidase, alpha, acid |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gab2 |
GRB2-associated binding protein 2 |
|
increases expression |
ISO |
1 |
154,348,777 |
154,544,906 |
RGD:6480464 |
CTD |
| G |
Galns |
galactosamine (N-acetyl)-6-sulfate sulfatase |
|
decreases expression |
ISO |
19 |
52,859,282 |
52,890,422 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
decreases expression |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
multiple interactions |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gatm |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
decreases expression |
ISO |
3 |
109,558,043 |
109,565,432 |
RGD:6480464 |
CTD |
| G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
|
increases expression |
ISO |
8 |
74,470,610 |
74,474,086 |
RGD:6480464 |
CTD |
| G |
Gdap2 |
ganglioside-induced differentiation-associated-protein 2 |
|
decreases expression |
ISO |
2 |
195,116,710 |
195,174,436 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gimap7 |
GTPase, IMAP family member 7 |
|
increases expression |
ISO |
4 |
76,812,445 |
76,816,615 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gk |
glycerol kinase |
|
increases expression |
EXP |
X |
72,416,872 |
72,493,296 |
RGD:6480464 |
CTD |
| G |
Gli1 |
GLI family zinc finger 1 |
|
multiple interactions |
ISO |
7 |
67,288,291 |
67,297,461 |
RGD:6480464 |
CTD |
| G |
Glod4 |
glyoxalase domain containing 4 |
|
increases expression |
ISO |
10 |
63,575,440 |
63,600,076 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Glycam1 |
glycosylation dependent cell adhesion molecule 1 |
|
affects expression |
EXP |
7 |
142,455,642 |
142,457,902 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
increases expression |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
increases expression |
ISO |
19 |
11,472,083 |
11,623,600 |
RGD:6480464 |
CTD |
| G |
Gnb4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
|
increases expression |
ISO |
2 |
118,791,192 |
118,827,413 |
RGD:6480464 |
CTD |
| G |
Gosr2 |
golgi SNAP receptor complex member 2 |
|
increases expression |
EXP |
10 |
92,830,987 |
92,850,289 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
increases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpr155 |
G protein-coupled receptor 155 |
|
increases expression |
ISO |
3 |
55,846,337 |
55,900,086 |
RGD:6480464 |
CTD |
| G |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
affects expression |
EXP |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
multiple interactions |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
increases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
increases expression |
EXP |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
increases expression |
ISO |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
decreases expression |
EXP |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
EXP |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
affects expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects localization |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
increases expression |
EXP |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects localization |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
increases expression |
ISO |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gucy1a3 |
guanylate cyclase 1, soluble, alpha 3 |
|
decreases expression |
EXP |
2 |
173,756,824 |
173,818,316 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
decreases expression |
EXP |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
multiple interactions |
EXP |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
multiple interactions |
EXP |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
decreases expression |
EXP |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
decreases expression |
EXP |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
increases expression |
ISO |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
increases expression |
ISO |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
Hbg1 |
hemoglobin, gamma A |
|
increases expression |
ISO |
1 |
161,640,359 |
161,641,737 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
multiple interactions |
ISO |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hdac7 |
histone deacetylase 7 |
|
increases expression |
ISO |
7 |
136,501,738 |
136,523,073 |
RGD:6480464 |
CTD |
| G |
Hdac9 |
histone deacetylase 9 |
|
increases expression |
ISO |
6 |
53,066,308 |
53,114,402 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
increases expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hdhd2 |
haloacid dehalogenase-like hydrolase domain containing 2 |
|
increases expression |
ISO |
18 |
73,896,018 |
73,948,475 |
RGD:6480464 |
CTD |
| G |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
|
decreases expression |
ISO |
17 |
58,856,317 |
59,275,923 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
increases expression |
ISO |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
decreases expression |
ISO |
2 |
27,649,188 |
27,672,231 |
RGD:6480464 |
CTD |
| G |
Hfe |
hemochromatosis |
|
decreases expression |
ISO |
17 |
48,469,927 |
48,478,502 |
RGD:6480464 |
CTD |
| G |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
|
decreases expression |
ISO |
1 |
77,377,465 |
77,408,704 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet-associated |
|
increases expression |
ISO |
4 |
56,146,654 |
56,147,441 |
RGD:6480464 |
CTD |
| G |
Hist1h2aa |
histone cluster 1, H2aa |
|
decreases expression |
ISO |
17 |
48,289,528 |
48,289,920 |
RGD:6480464 |
CTD |
| G |
Hlcs |
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
|
increases expression |
EXP |
11 |
34,382,010 |
34,539,032 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
increases activity |
EXP |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
increases expression |
ISO |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 (H') |
|
increases expression |
ISO |
X |
122,056,647 |
122,061,844 |
RGD:6480464 |
CTD |
| G |
Hopx |
HOP homeobox |
|
increases expression |
ISO |
14 |
33,369,052 |
33,377,948 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
decreases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
decreases activity |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
decreases activity |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
decreases expression |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
increases activity |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases expression |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
affects expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
affects expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
affects expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
affects expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
affects binding |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
decreases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
affects expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
affects expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
affects expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
EXP |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
affects expression |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
decreases expression |
EXP |
8 |
86,700,088 |
86,701,248 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
affects expression |
EXP |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
increases expression |
ISO |
4 |
2,707,261 |
2,716,944 |
RGD:6480464 |
CTD |
| G |
Hyou1 |
hypoxia up-regulated 1 |
|
decreases expression |
ISO |
8 |
47,346,753 |
47,358,869 |
RGD:6480464 |
CTD |
| G |
Iars |
isoleucyl-tRNA synthetase |
|
increases expression |
EXP |
17 |
20,895,852 |
20,942,180 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
increases expression |
ISO |
16 |
71,866,340 |
71,878,373 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifi35 |
interferon-induced protein 35 |
|
decreases expression |
ISO |
10 |
90,475,323 |
90,483,575 |
RGD:6480464 |
CTD |
| G |
Ifi44l |
interferon-induced protein 44-like |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifitm6 |
interferon induced transmembrane protein 6 |
|
increases expression |
ISO |
1 |
201,204,645 |
201,205,945 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
affects expression |
EXP |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
multiple interactions |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
|
affects expression |
EXP |
5 |
62,324,324 |
62,339,729 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10ra |
interleukin 10 receptor, alpha |
|
increases expression |
ISO |
8 |
48,211,040 |
48,224,439 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
decreases expression |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
affects expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il18bp |
interleukin 18 binding protein |
|
decreases expression |
ISO |
1 |
159,471,809 |
159,473,288 |
RGD:6480464 |
CTD |
| G |
Il18rap |
interleukin 18 receptor accessory protein |
|
increases expression |
ISO |
9 |
39,676,026 |
39,677,475 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rl2 |
interleukin 1 receptor-like 2 |
|
increases expression |
ISO |
9 |
39,492,187 |
39,537,792 |
RGD:6480464 |
CTD |
| G |
Il20 |
interleukin 20 |
|
increases expression |
ISO |
13 |
43,860,611 |
43,863,964 |
RGD:6480464 |
CTD |
| G |
Il21 |
interleukin 21 |
|
increases expression |
ISO |
2 |
123,774,331 |
123,781,697 |
RGD:6480464 |
CTD |
| G |
Il31 |
interleukin 31 |
|
increases expression |
ISO |
12 |
34,241,470 |
34,243,890 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il7 |
interleukin 7 |
|
increases expression |
ISO |
2 |
96,356,083 |
96,399,796 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
increases expression |
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
increases expression |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inpp1 |
inositol polyphosphate-1-phosphatase |
|
decreases expression |
ISO |
9 |
45,681,642 |
45,693,321 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Irf4 |
interferon regulatory factor 4 |
|
decreases expression |
ISO |
17 |
40,170,409 |
40,189,976 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
decreases expression |
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
decreases expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
increases expression |
ISO |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
multiple interactions |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgbl1 |
integrin, beta-like 1 |
|
decreases expression |
EXP |
15 |
108,785,509 |
109,051,028 |
RGD:6480464 |
CTD |
| G |
Itpkc |
inositol-trisphosphate 3-kinase C |
|
decreases expression |
ISO |
1 |
82,284,846 |
82,306,422 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
increases expression |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Ivd |
isovaleryl-CoA dehydrogenase |
|
increases expression |
ISO |
3 |
105,374,429 |
105,394,861 |
RGD:6480464 |
CTD |
| G |
Jkamp |
JNK1/MAPK8-associated membrane protein |
|
decreases expression |
ISO |
6 |
94,281,853 |
94,295,840 |
RGD:6480464 |
CTD |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
decreases expression |
ISO |
10 |
106,942,942 |
106,948,652 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kalrn |
kalirin, RhoGEF kinase |
|
increases expression |
ISO |
11 |
68,124,348 |
68,611,336 |
RGD:6480464 |
CTD |
| G |
Kat6a |
K(lysine) acetyltransferase 6A |
|
increases expression |
ISO |
16 |
73,553,868 |
73,634,794 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
decreases expression |
ISO |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kctd1 |
potassium channel tetramerisation domain containing 1 |
|
increases expression |
ISO |
18 |
6,225,049 |
6,324,832 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif11 |
kinesin family member 11 |
|
decreases expression |
ISO |
1 |
241,668,938 |
241,722,847 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
decreases expression |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kirrel3 |
kin of IRRE like 3 (Drosophila) |
|
increases expression |
ISO |
8 |
34,300,350 |
34,835,957 |
RGD:6480464 |
CTD |
| G |
Kl |
Klotho |
|
affects expression |
EXP |
12 |
3,732,712 |
3,772,371 |
RGD:6480464 |
CTD |
| G |
Klhdc2 |
kelch domain containing 2 |
|
decreases expression |
ISO |
6 |
91,259,826 |
91,274,820 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
decreases expression |
EXP |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Ky |
kyphoscoliosis peptidase |
|
increases expression |
ISO |
8 |
107,471,604 |
107,511,797 |
RGD:6480464 |
CTD |
| G |
Lair1 |
leukocyte-associated immunoglobulin-like receptor 1 |
|
decreases expression |
ISO |
1 |
69,571,996 |
69,601,974 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
affects expression |
EXP |
18 |
4,030,463 |
4,121,355 |
RGD:6480464 |
CTD |
| G |
Larp1 |
La ribonucleoprotein domain family, member 1 |
|
increases expression |
EXP |
10 |
43,608,207 |
43,676,236 |
RGD:6480464 |
CTD |
| G |
Lat |
linker for activation of T cells |
|
decreases expression |
ISO |
1 |
185,450,155 |
185,455,180 |
RGD:6480464 |
CTD |
| G |
Lat2 |
linker for activation of T cells family, member 2 |
|
increases expression |
ISO |
12 |
23,174,554 |
23,180,908 |
RGD:6480464 |
CTD |
| G |
Lbh |
limb bud and heart development |
|
decreases expression |
ISO |
6 |
22,662,376 |
22,664,667 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
ISO |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
increases expression |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
Lcp1 |
lymphocyte cytosolic protein 1 |
|
increases expression |
ISO |
15 |
56,034,457 |
56,091,880 |
RGD:6480464 |
CTD |
| G |
Ldb1 |
LIM domain binding 1 |
|
decreases expression |
ISO |
1 |
251,253,305 |
251,260,850 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
affects expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldlrad3 |
low density lipoprotein receptor class A domain containing 3 |
|
increases expression |
ISO |
3 |
87,108,483 |
87,275,069 |
RGD:6480464 |
CTD |
| G |
Ldoc1l |
leucine zipper, down-regulated in cancer 1-like |
|
increases expression |
ISO |
7 |
122,569,018 |
122,570,166 |
RGD:6480464 |
CTD |
| G |
Lhfpl4 |
lipoma HMGIC fusion partner-like 4 |
|
decreases expression |
ISO |
4 |
149,049,668 |
149,072,608 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
increases expression |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
LOC679835 |
similar to Anionic trypsin II precursor (Pretrypsinogen II) |
|
increases expression |
ISO |
4 |
69,144,579 |
69,149,045 |
RGD:6480464 |
CTD |
| G |
Lpar6 |
lysophosphatidic acid receptor 6 |
|
decreases expression |
ISO |
15 |
53,875,463 |
53,877,272 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrmp |
lymphoid-restricted membrane protein |
|
decreases expression |
ISO |
4 |
182,769,091 |
182,823,096 |
RGD:6480464 |
CTD |
| G |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
|
increases expression |
ISO |
3 |
75,821,638 |
75,875,100 |
RGD:6480464 |
CTD |
| G |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
|
multiple interactions |
ISO |
14 |
81,292,661 |
81,304,670 |
RGD:6480464 |
CTD |
| G |
Lrrc23 |
leucine rich repeat containing 23 |
|
increases expression |
EXP |
4 |
160,899,357 |
160,909,547 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
decreases expression |
EXP |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Ly6g6c |
lymphocyte antigen 6 complex, locus G6C |
|
increases expression |
ISO |
20 |
3,817,976 |
3,820,673 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
increases expression |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Mag |
myelin-associated glycoprotein |
|
increases expression |
EXP |
1 |
85,954,511 |
85,970,832 |
RGD:6480464 |
CTD |
| G |
Magoh |
mago-nashi homolog, proliferation-associated (Drosophila) |
|
decreases expression |
ISO |
5 |
128,982,276 |
128,989,724 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
multiple interactions |
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
|
increases expression |
ISO |
9 |
39,087,924 |
39,213,053 |
RGD:6480464 |
CTD |
| G |
Map4k5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
|
increases expression |
ISO |
6 |
91,885,447 |
91,978,735 |
RGD:6480464 |
CTD |
| G |
Map6d1 |
MAP6 domain containing 1 |
|
increases expression |
ISO |
11 |
82,981,697 |
82,987,926 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk11 |
mitogen-activated protein kinase 11 |
|
increases expression |
ISO |
7 |
127,444,055 |
127,449,990 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk4 |
mitogen-activated protein kinase 4 |
|
multiple interactions |
ISO |
18 |
70,707,645 |
70,755,517 |
RGD:6480464 |
CTD |
| G |
Mapk6 |
mitogen-activated protein kinase 6 |
|
increases expression |
ISO |
8 |
80,212,726 |
80,236,362 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases expression |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
March7 |
membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
3 |
41,922,568 |
41,954,630 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
decreases expression |
EXP |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Mars |
methionyl-tRNA synthetase |
|
increases expression |
EXP |
7 |
67,252,510 |
67,269,807 |
RGD:6480464 |
CTD |
| G |
Mast2 |
microtubule associated serine/threonine kinase 2 |
|
increases expression |
ISO |
5 |
136,573,518 |
136,717,367 |
RGD:6480464 |
CTD |
| G |
Mat2a |
methionine adenosyltransferase II, alpha |
|
decreases expression |
ISO |
4 |
105,739,943 |
105,745,472 |
RGD:6480464 |
CTD |
| G |
Matk |
megakaryocyte-associated tyrosine kinase |
|
multiple interactions |
ISO |
7 |
9,940,799 |
9,945,824 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
decreases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mcc |
mutated in colorectal cancers |
|
multiple interactions |
ISO |
18 |
38,099,803 |
38,576,214 |
RGD:6480464 |
CTD |
| G |
Mcf2 |
MCF.2 cell line derived transforming sequence |
|
multiple interactions |
ISO |
X |
145,597,430 |
145,693,790 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
decreases expression |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mdk |
midkine |
|
decreases expression |
EXP |
3 |
76,309,988 |
76,311,345 |
RGD:6480464 |
CTD |
| G |
Mdp1 |
magnesium-dependent phosphatase 1 |
|
decreases expression |
ISO |
15 |
33,792,908 |
33,795,806 |
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mfrp |
membrane frizzled-related protein |
|
affects expression |
EXP |
8 |
47,084,056 |
47,089,218 |
RGD:6480464 |
CTD |
| G |
Mfsd11 |
major facilitator superfamily domain containing 11 |
|
increases expression |
ISO |
10 |
106,957,529 |
106,973,225 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mid1 |
midline 1 (Opitz/BBB syndrome) |
|
increases expression |
ISO |
X |
44,751,950 |
44,879,999 |
RGD:6480464 |
CTD |
| G |
Mink1 |
misshapen-like kinase 1 |
|
increases expression |
ISO |
10 |
57,443,253 |
57,496,763 |
RGD:6480464 |
CTD |
| G |
Mios |
missing oocyte, meiosis regulator, homolog (Drosophila) |
|
increases expression |
ISO |
4 |
33,269,491 |
33,288,953 |
RGD:6480464 |
CTD |
| G |
Mitf |
microphthalmia-associated transcription factor |
|
increases expression |
ISO |
4 |
132,534,187 |
132,745,669 |
RGD:6480464 |
CTD |
| G |
Mlec |
malectin |
|
increases expression |
ISO |
12 |
42,729,870 |
42,740,346 |
RGD:6480464 |
CTD |
| G |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
|
increases expression |
ISO |
5 |
107,070,371 |
107,088,371 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
affects expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp25 |
matrix metallopeptidase 25 |
|
increases expression |
ISO |
10 |
12,894,707 |
12,907,837 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mogat2 |
monoacylglycerol O-acyltransferase 2 |
|
increases expression |
ISO |
1 |
156,516,531 |
156,540,899 |
RGD:6480464 |
CTD |
| G |
Morf4l2 |
mortality factor 4 like 2 |
|
decreases expression |
ISO |
X |
124,382,809 |
124,393,906 |
RGD:6480464 |
CTD |
| G |
Mpeg1 |
macrophage expressed 1 |
|
increases expression |
ISO |
1 |
215,387,912 |
215,390,172 |
RGD:6480464 |
CTD |
| G |
Mpp6 |
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
|
decreases expression |
EXP |
4 |
78,343,494 |
78,424,470 |
RGD:6480464 |
CTD |
| G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
|
increases expression |
ISO |
4 |
116,207,542 |
116,211,771 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
multiple interactions |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases response to substance |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
decreases response to substance |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mtfr1l |
mitochondrial fission regulator 1-like |
|
increases expression |
ISO |
5 |
153,282,197 |
153,291,993 |
RGD:6480464 |
CTD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
increases expression |
EXP |
4 |
117,517,611 |
117,529,128 |
RGD:6480464 |
CTD |
| G |
Mtmr10 |
myotubularin related protein 10 |
|
decreases expression |
ISO |
1 |
118,726,116 |
118,777,543 |
RGD:6480464 |
CTD |
| G |
Mtx1 |
Metaxin 1 |
|
increases expression |
ISO |
2 |
181,379,690 |
181,381,406 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
increases expression |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Mycn |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
|
multiple interactions |
ISO |
6 |
36,508,262 |
36,514,071 |
RGD:6480464 |
CTD |
| G |
Myo6 |
myosin VI |
|
decreases expression |
ISO |
8 |
85,203,987 |
85,368,026 |
RGD:6480464 |
CTD |
| G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
|
decreases expression |
ISO |
12 |
4,184,417 |
4,205,550 |
RGD:6480464 |
CTD |
| G |
Naa20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
|
increases expression |
ISO |
3 |
134,522,185 |
134,537,185 |
RGD:6480464 |
CTD |
| G |
Naga |
N-acetyl galactosaminidase, alpha |
|
increases expression |
ISO |
7 |
120,706,129 |
120,714,429 |
RGD:6480464 |
CTD |
| G |
Nars |
asparaginyl-tRNA synthetase |
|
increases expression |
EXP |
18 |
60,719,399 |
60,736,058 |
RGD:6480464 |
CTD |
| G |
Ncstn |
nicastrin |
|
increases expression |
ISO |
13 |
88,060,484 |
88,076,493 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndufa7 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 |
|
decreases expression |
ISO |
7 |
16,322,027 |
16,334,210 |
RGD:6480464 |
CTD |
| G |
Ndufa7l |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7-like |
|
decreases expression |
ISO |
3 |
55,312,099 |
55,312,440 |
RGD:6480464 |
CTD |
| G |
Ndufa9 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 |
|
decreases expression |
ISO |
4 |
163,208,781 |
163,237,542 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
decreases expression |
ISO |
1 |
180,908,331 |
180,921,734 |
RGD:6480464 |
CTD |
| G |
Ndufc1 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 |
|
increases expression |
ISO |
2 |
140,298,031 |
140,301,809 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
increases expression |
ISO |
9 |
61,798,141 |
61,831,964 |
RGD:6480464 |
CTD |
| G |
Nefh |
neurofilament, heavy polypeptide |
|
increases expression |
ISO |
14 |
85,594,789 |
85,604,774 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
increases expression |
ISO |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
affects expression |
ISO |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Nelfa |
negative elongation factor complex member A |
|
increases expression |
ISO |
14 |
82,502,840 |
82,526,916 |
RGD:6480464 |
CTD |
| G |
Neurl4 |
neuralized homolog 4 (Drosophila) |
|
increases expression |
ISO |
10 |
56,745,822 |
56,757,435 |
RGD:6480464 |
CTD |
| G |
Nfasc |
neurofascin |
|
increases expression |
ISO |
13 |
45,450,550 |
45,637,877 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
multiple interactions |
ISO |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfya |
nuclear transcription factor-Y alpha |
|
increases expression |
ISO |
9 |
7,970,040 |
7,994,375 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases activity |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nif3l1 |
NIF3 NGG1 interacting factor 3-like 1 (S. cerevisiae) |
|
increases expression |
ISO |
9 |
57,105,338 |
57,122,976 |
RGD:6480464 |
CTD |
| G |
Nin |
ninein (GSK3B interacting protein) |
|
decreases expression |
ISO |
6 |
92,135,196 |
92,229,044 |
RGD:6480464 |
CTD |
| G |
Nmbr |
neuromedin B receptor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
increases expression |
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch2 |
notch 2 |
|
increases expression |
ISO |
2 |
192,839,350 |
192,986,589 |
RGD:6480464 |
CTD |
| G |
Npepl1 |
aminopeptidase-like 1 |
|
increases expression |
ISO |
3 |
165,035,886 |
165,047,727 |
RGD:6480464 |
CTD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
increases expression |
EXP |
2 |
182,724,916 |
182,740,242 |
RGD:6480464 |
CTD |
| G |
Npy1r |
neuropeptide Y receptor Y1 |
|
increases expression |
EXP |
16 |
24,747,183 |
24,756,507 |
RGD:6480464 |
CTD |
| G |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
|
decreases expression |
ISO |
1 |
125,280,974 |
125,286,929 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
decreases expression |
EXP |
18 |
25,842,127 |
25,868,219 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
affects expression |
ISO |
11 |
15,066,443 |
15,150,137 |
RGD:6480464 |
CTD |
| G |
Nsg1 |
neuron specific gene family member 1 |
|
decreases expression |
EXP |
14 |
77,931,947 |
77,953,690 |
RGD:6480464 |
CTD |
| G |
Nsmce1 |
non-SMC element 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
184,528,343 |
184,553,824 |
RGD:6480464 |
CTD |
| G |
Nsun3 |
NOP2/Sun domain family, member 3 |
|
increases expression |
ISO |
11 |
38,158,332 |
38,234,163 |
RGD:6480464 |
CTD |
| G |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
|
multiple interactions |
ISO |
10 |
13,883,284 |
13,889,790 |
RGD:6480464 |
CTD |
| G |
Nuak2 |
NUAK family, SNF1-like kinase, 2 |
|
increases expression |
ISO |
13 |
45,205,573 |
45,222,322 |
RGD:6480464 |
CTD |
| G |
Olfml3 |
olfactomedin-like 3 |
|
increases expression |
ISO |
2 |
198,958,480 |
198,961,309 |
RGD:6480464 |
CTD |
| G |
Olr145 |
olfactory receptor 145 |
|
increases expression |
ISO |
1 |
161,912,324 |
161,913,268 |
RGD:6480464 |
CTD |
| G |
Olr1475 |
olfactory receptor 1475 |
|
increases expression |
ISO |
10 |
60,446,655 |
60,447,593 |
RGD:6480464 |
CTD |
| G |
Olr185 |
olfactory receptor 185 |
|
increases expression |
ISO |
1 |
162,803,635 |
162,804,588 |
RGD:6480464 |
CTD |
| G |
Olr39 |
olfactory receptor 39 |
|
increases expression |
ISO |
1 |
160,073,273 |
160,074,262 |
RGD:6480464 |
CTD |
| G |
Olr392 |
olfactory receptor 392 |
|
decreases expression |
ISO |
2 |
202,281,083 |
202,282,033 |
RGD:6480464 |
CTD |
| G |
Olr484 |
olfactory receptor 484 |
|
increases expression |
ISO |
3 |
69,378,937 |
69,379,884 |
RGD:6480464 |
CTD |
| G |
Olr646 |
olfactory receptor 646 |
|
increases expression |
ISO |
3 |
72,635,560 |
72,636,480 |
RGD:6480464 |
CTD |
| G |
Olr675 |
olfactory receptor 675 |
|
increases expression |
ISO |
3 |
73,349,232 |
73,350,167 |
RGD:6480464 |
CTD |
| G |
Olr686 |
olfactory receptor 686 |
|
increases expression |
ISO |
3 |
73,534,539 |
73,535,474 |
RGD:6480464 |
CTD |
| G |
Osm |
oncostatin M |
|
increases expression |
ISO |
14 |
84,857,232 |
84,860,082 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
increases expression |
ISO |
2 |
56,080,700 |
56,121,463 |
RGD:6480464 |
CTD |
| G |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
|
decreases expression |
ISO |
2 |
228,112,093 |
228,127,992 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
decreases expression |
EXP |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
|
increases expression |
ISO |
1 |
209,871,581 |
209,879,518 |
RGD:6480464 |
CTD |
| G |
Otx2 |
orthodenticle homeobox 2 |
|
affects expression |
EXP |
15 |
24,622,851 |
24,632,435 |
RGD:6480464 |
CTD |
| G |
Oxct2a |
3-oxoacid CoA transferase 2A |
|
decreases expression |
ISO |
5 |
142,636,815 |
142,638,554 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases expression |
EXP |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
increases expression |
ISO |
1 |
158,381,127 |
158,406,783 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
decreases expression |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Pabpn1 |
poly(A) binding protein, nuclear 1 |
|
decreases expression |
ISO |
15 |
32,994,493 |
32,999,104 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pbxip1 |
pre-B-cell leukemia homeobox interacting protein 1 |
|
affects expression |
EXP |
2 |
181,637,864 |
181,647,769 |
RGD:6480464 |
CTD |
| G |
Pcyox1 |
prenylcysteine oxidase 1 |
|
decreases expression |
ISO |
4 |
120,569,436 |
120,580,273 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
multiple interactions |
EXP |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
increases expression |
ISO |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
decreases expression |
ISO |
10 |
13,329,708 |
13,394,080 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
decreases expression |
EXP |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Peli2 |
pellino E3 ubiquitin protein ligase family member 2 |
|
increases expression |
ISO |
15 |
24,227,734 |
24,371,242 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
decreases expression |
ISO |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Pex2 |
peroxisomal biogenesis factor 2 |
|
decreases expression |
ISO |
2 |
98,361,891 |
98,378,715 |
RGD:6480464 |
CTD |
| G |
Pex6 |
peroxisomal biogenesis factor 6 |
|
increases expression |
ISO |
9 |
10,130,561 |
10,139,807 |
RGD:6480464 |
CTD |
| G |
Phf8 |
PHD finger protein 8 |
|
decreases expression |
ISO |
X |
40,869,942 |
40,970,244 |
RGD:6480464 |
CTD |
| G |
Phka2 |
phosphorylase kinase, alpha 2 |
|
decreases expression |
ISO |
X |
55,463,178 |
55,580,783 |
RGD:6480464 |
CTD |
| G |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
|
multiple interactions |
ISO |
1 |
227,689,733 |
227,961,671 |
RGD:6480464 |
CTD |
| G |
Pkd1l3 |
polycystic kidney disease 1-like 3 |
|
increases expression |
ISO |
19 |
39,489,363 |
39,555,398 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
increases expression |
EXP |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
increases expression |
ISO |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
increases expression |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
affects expression |
EXP |
5 |
157,619,703 |
157,640,971 |
RGD:6480464 |
CTD |
| G |
Plac8 |
placenta-specific 8 |
|
decreases expression |
ISO |
14 |
10,302,667 |
10,325,559 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
increases expression |
ISO |
1 |
242,794,858 |
243,103,437 |
RGD:6480464 |
CTD |
| G |
Pld4 |
phospholipase D family, member 4 |
|
increases expression |
ISO |
6 |
137,744,704 |
137,752,222 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
increases expression |
ISO |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
decreases expression |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Pmm2 |
phosphomannomutase 2 |
|
increases expression |
ISO |
10 |
7,001,340 |
7,022,517 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
increases expression |
ISO |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
ISO |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pole4 |
polymerase (DNA-directed), epsilon 4, accessory subunit |
|
decreases expression |
ISO |
4 |
116,856,445 |
116,862,256 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
affects expression |
EXP |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pop5 |
processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) |
|
increases expression |
ISO |
12 |
42,644,912 |
42,649,407 |
RGD:6480464 |
CTD |
| G |
Pou2f2 |
POU class 2 homeobox 2 |
|
increases activity |
EXP |
1 |
80,405,061 |
80,442,677 |
RGD:6480464 |
CTD |
| G |
Pou2f2 |
POU class 2 homeobox 2 |
|
increases expression |
EXP |
1 |
80,405,061 |
80,442,677 |
RGD:6480464 |
CTD |
| G |
Pou4f1 |
POU class 4 homeobox 1 |
|
decreases expression |
EXP |
15 |
88,535,625 |
88,539,256 |
RGD:6480464 |
CTD |
| G |
Pou4f2 |
POU class 4 homeobox 2 |
|
increases expression |
ISO |
19 |
31,388,907 |
31,392,548 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
increases expression |
ISO |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppcdc |
phosphopantothenoylcysteine decarboxylase |
|
increases expression |
ISO |
8 |
61,153,582 |
61,177,682 |
RGD:6480464 |
CTD |
| G |
Ppcs |
phosphopantothenoylcysteine synthetase |
|
decreases expression |
ISO |
5 |
140,008,434 |
140,012,295 |
RGD:6480464 |
CTD |
| G |
Ppm1g |
protein phosphatase, Mg2+/Mn2+ dependent, 1G |
|
decreases expression |
ISO |
6 |
25,145,569 |
25,149,811 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
increases expression |
EXP |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Ppp6r3 |
protein phosphatase 6, regulatory subunit 3 |
|
decreases expression |
ISO |
1 |
205,980,403 |
206,096,001 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
decreases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
decreases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prelp |
proline/arginine-rich end leucine-rich repeat protein |
|
increases expression |
ISO |
13 |
46,863,392 |
46,874,172 |
RGD:6480464 |
CTD |
| G |
Prickle3 |
prickle homolog 3 (Drosophila) |
|
increases expression |
ISO |
X |
26,878,508 |
26,889,077 |
RGD:6480464 |
CTD |
| G |
Prkar1a |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
|
increases expression |
ISO |
10 |
148,642,200 |
148,642,454 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
decreases expression |
EXP |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
decreases expression |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
decreases expression |
EXP |
1 |
64,145,749 |
64,172,712 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
increases expression |
ISO |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkci |
protein kinase C, iota |
|
decreases expression |
EXP |
2 |
116,739,625 |
116,801,084 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
increases expression |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
decreases expression |
EXP |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Procr |
protein C receptor, endothelial |
|
increases expression |
ISO |
3 |
146,268,567 |
146,273,718 |
RGD:6480464 |
CTD |
| G |
Prpsap2 |
phosphoribosyl pyrophosphate synthetase-associated protein 2 |
|
increases expression |
ISO |
10 |
47,890,667 |
47,925,430 |
RGD:6480464 |
CTD |
| G |
Prss2 |
protease, serine, 2 |
|
increases expression |
ISO |
4 |
69,088,288 |
69,093,312 |
RGD:6480464 |
CTD |
| G |
Psmb7 |
proteasome (prosome, macropain) subunit, beta type 7 |
|
decreases expression |
ISO |
3 |
18,384,197 |
18,451,208 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
increases expression |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psme2 |
proteasome (prosome, macropain) activator subunit 2 |
|
increases expression |
ISO |
15 |
33,722,370 |
33,726,669 |
RGD:6480464 |
CTD |
| G |
Psph |
phosphoserine phosphatase |
|
decreases expression |
EXP |
12 |
27,969,748 |
27,984,318 |
RGD:6480464 |
CTD |
| G |
Ptchd2 |
patched domain containing 2 |
|
increases expression |
ISO |
5 |
165,319,196 |
165,366,774 |
RGD:6480464 |
CTD |
| G |
Ptges3 |
prostaglandin E synthase 3 (cytosolic) |
|
decreases expression |
ISO |
7 |
1,351,206 |
1,368,857 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
multiple interactions |
ISO |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
decreases expression |
ISO |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
|
decreases expression |
ISO |
18 |
64,205,920 |
64,271,288 |
RGD:6480464 |
CTD |
| G |
Ptprcap |
protein tyrosine phosphatase, receptor type, C-associated protein |
|
increases expression |
ISO |
1 |
206,738,735 |
206,740,894 |
RGD:6480464 |
CTD |
| G |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
|
increases expression |
EXP |
9 |
74,528,095 |
74,542,756 |
RGD:6480464 |
CTD |
| G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
|
decreases expression |
ISO |
4 |
174,376,396 |
174,586,694 |
RGD:6480464 |
CTD |
| G |
Qars |
glutaminyl-tRNA synthetase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rab11fip2 |
RAB11 family interacting protein 2 (class I) |
|
decreases expression |
ISO |
1 |
266,461,752 |
266,497,576 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
decreases expression |
ISO |
3 |
14,245,693 |
14,255,984 |
RGD:6480464 |
CTD |
| G |
Rab34 |
RAB34, member RAS oncogene family |
|
decreases expression |
ISO |
10 |
64,443,111 |
64,447,315 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases expression |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases phosphorylation |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rag2 |
recombination activating gene 2 |
|
increases expression |
ISO |
3 |
86,764,810 |
86,773,438 |
RGD:6480464 |
CTD |
| G |
Ralgapa1 |
Ral GTPase activating protein, alpha subunit 1 (catalytic) |
|
increases expression |
ISO |
6 |
75,849,629 |
76,163,553 |
RGD:6480464 |
CTD |
| G |
Rapgefl1 |
Rap guanine nucleotide exchange factor (GEF)-like 1 |
|
increases expression |
ISO |
10 |
87,607,651 |
87,620,668 |
RGD:6480464 |
CTD |
| G |
Rars |
arginyl-tRNA synthetase |
|
decreases expression |
EXP |
10 |
20,721,170 |
20,745,484 |
RGD:6480464 |
CTD |
| G |
Rbm24 |
RNA binding motif protein 24 |
|
increases expression |
ISO |
17 |
24,217,930 |
24,229,736 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
|
increases expression |
ISO |
X |
26,379,303 |
26,382,739 |
RGD:6480464 |
CTD |
| G |
Rbm4 |
RNA binding motif protein 4 |
|
increases expression |
ISO |
1 |
207,394,470 |
207,403,393 |
RGD:6480464 |
CTD |
| G |
Rcvrn |
recoverin |
|
increases expression |
ISO |
10 |
54,409,087 |
54,416,833 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
multiple interactions |
ISO |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
RGD1562658 |
similar to RIKEN cDNA 1700009P17 |
|
affects expression |
EXP |
13 |
86,995,646 |
87,012,470 |
RGD:6480464 |
CTD |
| G |
Rgs18 |
regulator of G-protein signaling 18 |
|
affects expression |
EXP |
13 |
58,607,898 |
58,629,597 |
RGD:6480464 |
CTD |
| G |
Rgs19 |
regulator of G-protein signaling 19 |
|
decreases expression |
ISO |
3 |
170,839,907 |
170,844,746 |
RGD:6480464 |
CTD |
| G |
Rgs22 |
regulator of G-protein signaling 22 |
|
affects expression |
EXP |
7 |
71,526,062 |
71,645,945 |
RGD:6480464 |
CTD |
| G |
Rhebl1 |
Ras homolog enriched in brain like 1 |
|
increases expression |
ISO |
7 |
137,645,541 |
137,649,476 |
RGD:6480464 |
CTD |
| G |
Rit1 |
Ras-like without CAAX 1 |
|
increases expression |
ISO |
2 |
180,846,683 |
180,859,135 |
RGD:6480464 |
CTD |
| G |
Rnase1 |
ribonuclease, RNase A family, 1 (pancreatic) |
|
increases expression |
ISO |
15 |
27,123,440 |
27,124,991 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
increases expression |
ISO |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnaseh2c |
ribonuclease H2, subunit C |
|
decreases expression |
ISO |
1 |
208,232,298 |
208,233,903 |
RGD:6480464 |
CTD |
| G |
Rnf138 |
ring finger protein 138, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
18 |
12,764,220 |
12,788,635 |
RGD:6480464 |
CTD |
| G |
Rnf38 |
ring finger protein 38 |
|
decreases expression |
ISO |
5 |
60,600,918 |
60,631,312 |
RGD:6480464 |
CTD |
| G |
Rpl22 |
ribosomal protein L22 |
|
decreases expression |
ISO |
5 |
169,557,840 |
169,564,566 |
RGD:6480464 |
CTD |
| G |
Rpn1 |
ribophorin I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpp30 |
ribonuclease P/MRP subunit |
|
increases expression |
ISO |
1 |
240,286,366 |
240,309,222 |
RGD:6480464 |
CTD |
| G |
Rpp40 |
ribonuclease P/MRP 40 subunit |
|
increases expression |
ISO |
17 |
35,249,263 |
35,257,891 |
RGD:6480464 |
CTD |
| G |
Rps10 |
ribosomal protein S10 |
|
increases expression |
ISO |
20 |
5,849,327 |
5,853,893 |
RGD:6480464 |
CTD |
| G |
Rps10l1 |
ribosomal protein S10-like 1 |
|
increases expression |
ISO |
6 |
74,838,974 |
74,839,471 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
affects expression |
ISO |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-DMb |
RT1 class II, locus DMb |
|
increases expression |
ISO |
20 |
4,829,535 |
4,836,772 |
RGD:6480464 |
CTD |
| G |
RT1-DOa |
RT1 class II, locus DOa |
|
decreases expression |
ISO |
20 |
4,890,410 |
4,894,048 |
RGD:6480464 |
CTD |
| G |
Rtn4 |
reticulon 4 |
|
affects expression |
EXP |
14 |
110,725,089 |
110,772,578 |
RGD:6480464 |
CTD |
| G |
Rundc3b |
RUN domain containing 3B |
|
decreases expression |
ISO |
4 |
21,546,162 |
21,689,813 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
increases expression |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
increases expression |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
increases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
increases expression |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
increases expression |
EXP |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Sbno2 |
strawberry notch homolog 2 (Drosophila) |
|
increases expression |
ISO |
7 |
11,117,835 |
11,161,863 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Schip1 |
schwannomin interacting protein 1 |
|
increases expression |
ISO |
2 |
157,848,639 |
158,631,796 |
RGD:6480464 |
CTD |
| G |
Sdccag8 |
serologically defined colon cancer antigen 8 |
|
increases expression |
ISO |
13 |
92,612,281 |
92,802,650 |
RGD:6480464 |
CTD |
| G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
|
decreases expression |
ISO |
11 |
85,878,093 |
85,880,335 |
RGD:6480464 |
CTD |
| G |
Sdhb |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
|
decreases expression |
ISO |
5 |
159,818,669 |
159,839,772 |
RGD:6480464 |
CTD |
| G |
Sdr16c5 |
short chain dehydrogenase/reductase family 16C, member 5 |
|
decreases expression |
ISO |
5 |
17,339,715 |
17,361,781 |
RGD:6480464 |
CTD |
| G |
Sec14l5 |
SEC14-like 5 (S. cerevisiae) |
|
increases expression |
ISO |
10 |
10,512,385 |
10,551,084 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
increases expression |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
decreases expression |
ISO |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
increases expression |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
affects expression |
EXP |
16 |
73,030,458 |
73,067,304 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
decreases expression |
ISO |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
|
increases expression |
EXP |
7 |
67,494,470 |
67,499,540 |
RGD:6480464 |
CTD |
| G |
Siae |
sialic acid acetylesterase |
|
increases expression |
ISO |
8 |
38,854,154 |
38,889,452 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
decreases expression |
EXP |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
increases expression |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc16a5 |
solute carrier family 16, member 5 (monocarboxylic acid transporter 6) |
|
decreases expression |
ISO |
10 |
105,543,856 |
105,556,494 |
RGD:6480464 |
CTD |
| G |
Slc17a3 |
solute carrier family 17 (sodium phosphate), member 3 |
|
increases expression |
ISO |
17 |
48,599,049 |
48,620,786 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
EXP |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
affects expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc25a16 |
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
|
increases expression |
EXP |
20 |
25,259,020 |
25,287,344 |
RGD:6480464 |
CTD |
| G |
Slc25a28 |
solute carrier family 25 (mitochondrial iron transporter), member 28 |
|
increases expression |
ISO |
1 |
247,159,998 |
247,171,232 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
multiple interactions |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
|
decreases expression |
EXP |
3 |
149,342,399 |
149,347,124 |
RGD:6480464 |
CTD |
| G |
Slc38a2 |
solute carrier family 38, member 2 |
|
decreases expression |
ISO |
7 |
135,365,172 |
135,377,341 |
RGD:6480464 |
CTD |
| G |
Slc39a5 |
solute carrier family 39 (metal ion transporter), member 5 |
|
increases expression |
ISO |
7 |
1,686,969 |
1,692,393 |
RGD:6480464 |
CTD |
| G |
Slc4a5 |
solute carrier family 4, sodium bicarbonate cotransporter, member 5 |
|
affects expression |
EXP |
4 |
117,432,385 |
117,515,453 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
affects expression |
EXP |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a8 |
solute carrier family 5 (iodide transporter), member 8 |
|
decreases expression |
ISO |
7 |
25,585,545 |
25,626,486 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
affects expression |
EXP |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
decreases expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression |
EXP |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
increases expression |
EXP |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slco1a2 |
solute carrier organic anion transporter family, member 1A2 |
|
affects expression |
EXP |
4 |
179,790,209 |
179,851,288 |
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
multiple interactions |
ISO |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smad5 |
SMAD family member 5 |
|
multiple interactions |
ISO |
17 |
13,814,164 |
13,824,358 |
RGD:6480464 |
CTD |
| G |
Smad9 |
SMAD family member 9 |
|
multiple interactions |
ISO |
2 |
144,014,436 |
144,030,672 |
RGD:6480464 |
CTD |
| G |
Smim11 |
small integral membrane protein 11 |
|
decreases expression |
ISO |
11 |
32,294,155 |
32,303,989 |
RGD:6480464 |
CTD |
| G |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
|
decreases expression |
ISO |
20 |
36,821,916 |
36,844,891 |
RGD:6480464 |
CTD |
| G |
Smpdl3b |
sphingomyelin phosphodiesterase, acid-like 3B |
|
decreases expression |
ISO |
5 |
152,390,454 |
152,415,338 |
RGD:6480464 |
CTD |
| G |
Smtn |
smoothelin |
|
decreases expression |
ISO |
14 |
84,160,580 |
84,182,869 |
RGD:6480464 |
CTD |
| G |
Snx4 |
sorting nexin 4 |
|
increases expression |
ISO |
11 |
69,283,047 |
69,340,448 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
affects expression |
EXP |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
increases expression |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
increases expression |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
increases expression |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sp110 |
SP110 nuclear body protein |
|
increases expression |
ISO |
9 |
84,258,232 |
84,279,462 |
RGD:6480464 |
CTD |
| G |
Spa17 |
sperm autoantigenic protein 17 |
|
affects expression |
EXP |
8 |
38,843,007 |
38,852,080 |
RGD:6480464 |
CTD |
| G |
Spaca3 |
sperm acrosome associated 3 |
|
increases expression |
ISO |
10 |
69,083,140 |
69,090,699 |
RGD:6480464 |
CTD |
| G |
Spcs1 |
signal peptidase complex subunit 1 homolog (S. cerevisiae) |
|
affects expression |
ISO |
16 |
6,427,296 |
6,428,864 |
RGD:6480464 |
CTD |
| G |
Spcs2 |
signal peptidase complex subunit 2 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
157,197,975 |
157,217,400 |
RGD:6480464 |
CTD |
| G |
Spg21 |
spastic paraplegia 21 homolog (human) |
|
increases expression |
ISO |
8 |
69,710,883 |
69,738,352 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
multiple interactions |
ISO |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Spink2 |
serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor) |
|
increases expression |
ISO |
14 |
33,245,183 |
33,251,691 |
RGD:6480464 |
CTD |
| G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
|
decreases expression |
ISO |
5 |
167,014,271 |
167,025,579 |
RGD:6480464 |
CTD |
| G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
|
decreases expression |
ISO |
1 |
207,318,258 |
207,358,896 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases phosphorylation |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Sri |
sorcin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Srsf10 |
serine/arginine-rich splicing factor 10 |
|
decreases expression |
ISO |
5 |
154,637,426 |
154,645,826 |
RGD:6480464 |
CTD |
| G |
Srsf5 |
serine/arginine-rich splicing factor 5 |
|
decreases expression |
ISO |
6 |
104,728,286 |
104,732,982 |
RGD:6480464 |
CTD |
| G |
Ssbp1 |
single-stranded DNA binding protein 1, mitochondrial |
|
decreases expression |
ISO |
4 |
68,027,304 |
68,036,581 |
RGD:6480464 |
CTD |
| G |
Sspn |
sarcospan |
|
multiple interactions |
ISO |
4 |
183,546,152 |
183,579,911 |
RGD:6480464 |
CTD |
| G |
Sstr4 |
somatostatin receptor 4 |
|
decreases expression |
ISO |
3 |
137,150,419 |
137,152,284 |
RGD:6480464 |
CTD |
| G |
St13 |
suppression of tumorigenicity 13 |
|
affects expression |
ISO |
7 |
119,694,123 |
119,728,936 |
RGD:6480464 |
CTD |
| G |
St6galnac1 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
|
increases expression |
ISO |
10 |
106,837,311 |
106,881,619 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Steap1 |
six transmembrane epithelial antigen of the prostate 1 |
|
affects expression |
EXP |
4 |
24,962,598 |
24,973,106 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
decreases expression |
ISO |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stom |
stomatin |
|
multiple interactions |
ISO |
3 |
14,392,978 |
14,415,288 |
RGD:6480464 |
CTD |
| G |
Stra6 |
stimulated by retinoic acid 6 |
|
affects expression |
EXP |
8 |
61,920,772 |
61,939,791 |
RGD:6480464 |
CTD |
| G |
Stx1a |
syntaxin 1A (brain) |
|
increases expression |
EXP |
12 |
22,737,112 |
22,765,064 |
RGD:6480464 |
CTD |
| G |
Suclg1 |
succinate-CoA ligase, alpha subunit |
|
decreases expression |
ISO |
4 |
106,572,140 |
106,601,495 |
RGD:6480464 |
CTD |
| G |
Sycn |
syncollin |
|
increases expression |
ISO |
1 |
83,651,275 |
83,651,687 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
decreases expression |
EXP |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
multiple interactions |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Sytl3 |
synaptotagmin-like 3 |
|
decreases expression |
ISO |
1 |
41,121,373 |
41,177,695 |
RGD:6480464 |
CTD |
| G |
Tars |
threonyl-tRNA synthetase |
|
increases expression |
EXP |
2 |
60,765,899 |
60,784,665 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
decreases expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tbc1d16 |
TBC1 domain family, member 16 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tbcd |
tubulin folding cofactor D |
|
decreases expression |
ISO |
10 |
110,676,187 |
110,717,621 |
RGD:6480464 |
CTD |
| G |
Tbrg1 |
transforming growth factor beta regulator 1 |
|
increases expression |
ISO |
8 |
38,890,730 |
38,898,388 |
RGD:6480464 |
CTD |
| G |
Tex101 |
testis expressed 101 |
|
decreases expression |
ISO |
1 |
79,946,338 |
79,949,053 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
increases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 |
|
increases expression |
ISO |
20 |
9,492,341 |
9,510,558 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
affects expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgoln2 |
trans-golgi network protein 2 |
|
decreases expression |
ISO |
4 |
106,110,153 |
106,117,906 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
increases expression |
ISO |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Thbs2 |
thrombospondin 2 |
|
decreases expression |
EXP |
1 |
53,584,406 |
53,613,652 |
RGD:6480464 |
CTD |
| G |
Thoc5 |
THO complex 5 |
|
decreases expression |
ISO |
14 |
85,561,381 |
85,612,915 |
RGD:6480464 |
CTD |
| G |
Tjp3 |
tight junction protein 3 |
|
increases expression |
ISO |
7 |
9,917,359 |
9,930,081 |
RGD:6480464 |
CTD |
| G |
Tln2 |
talin 2 |
|
decreases expression |
ISO |
8 |
71,532,270 |
71,964,142 |
RGD:6480464 |
CTD |
| G |
Tlr9 |
toll-like receptor 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlx1 |
T-cell leukemia, homeobox 1 |
|
increases expression |
ISO |
1 |
250,255,343 |
250,261,604 |
RGD:6480464 |
CTD |
| G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
|
multiple interactions |
ISO |
2 |
146,521,188 |
146,530,382 |
RGD:6480464 |
CTD |
| G |
Tmed4 |
transmembrane emp24 protein transport domain containing 4 |
|
increases expression |
ISO |
14 |
86,997,282 |
87,001,869 |
RGD:6480464 |
CTD |
| G |
Tmem176a |
transmembrane protein 176A |
|
increases expression |
ISO |
4 |
76,919,918 |
76,923,598 |
RGD:6480464 |
CTD |
| G |
Tmem204 |
transmembrane protein 204 |
|
increases expression |
ISO |
10 |
14,304,565 |
14,329,967 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
increases expression |
ISO |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Tmtc4 |
transmembrane and tetratricopeptide repeat containing 4 |
|
increases expression |
ISO |
15 |
108,061,644 |
108,118,409 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
increases expression |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf13b |
tumor necrosis factor (ligand) superfamily, member 13b |
|
increases expression |
ISO |
16 |
84,837,266 |
84,856,103 |
RGD:6480464 |
CTD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
increases expression |
ISO |
3 |
3,692,740 |
3,717,332 |
RGD:6480464 |
CTD |
| G |
Trat1 |
T cell receptor associated transmembrane adaptor 1 |
|
increases expression |
ISO |
11 |
53,279,300 |
53,321,892 |
RGD:6480464 |
CTD |
| G |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
|
increases expression |
ISO |
9 |
8,133,088 |
8,160,100 |
RGD:6480464 |
CTD |
| G |
Trim42 |
tripartite motif-containing 42 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Trim59 |
tripartite motif-containing 59 |
|
increases expression |
ISO |
2 |
159,016,206 |
159,027,069 |
RGD:6480464 |
CTD |
| G |
Trim65 |
tripartite motif-containing 65 |
|
decreases expression |
ISO |
10 |
106,232,274 |
106,237,808 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases expression |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases expression |
EXP |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
increases expression |
EXP |
2 |
143,350,286 |
143,485,716 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
affects expression |
EXP |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Try4 |
trypsin 4 |
|
increases expression |
ISO |
4 |
69,011,939 |
69,015,413 |
RGD:6480464 |
CTD |
| G |
Try4 |
trypsin 4 |
|
increases expression |
ISO |
4 |
69,011,939 |
69,015,413 |
RGD:6480464 |
CTD |
| G |
try5 |
trypsin 5 |
|
increases expression |
ISO |
4 |
69,022,611 |
69,025,885 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
affects expression |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
decreases expression |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tspan13 |
tetraspanin 13 |
|
increases expression |
ISO |
6 |
54,726,558 |
54,753,312 |
RGD:6480464 |
CTD |
| G |
Tspan32 |
tetraspanin 32 |
|
decreases expression |
ISO |
1 |
203,281,261 |
203,295,227 |
RGD:6480464 |
CTD |
| G |
Tsr2 |
TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ttc8 |
tetratricopeptide repeat domain 8 |
|
increases expression |
ISO |
6 |
123,117,534 |
123,171,840 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
increases expression |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Uba2 |
ubiquitin-like modifier activating enzyme 2 |
|
decreases expression |
ISO |
1 |
86,605,412 |
86,633,144 |
RGD:6480464 |
CTD |
| G |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
|
decreases expression |
ISO |
8 |
43,992,862 |
44,135,847 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
decreases expression |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ube3d |
ubiquitin protein ligase E3D |
|
increases expression |
ISO |
8 |
91,537,389 |
91,704,052 |
RGD:6480464 |
CTD |
| G |
Ubfd1 |
ubiquitin family domain containing 1 |
|
increases expression |
ISO |
1 |
180,889,833 |
180,901,230 |
RGD:6480464 |
CTD |
| G |
Ubp1 |
upstream binding protein 1 (LBP-1a) |
|
decreases expression |
ISO |
8 |
118,574,348 |
118,618,657 |
RGD:6480464 |
CTD |
| G |
Uhmk1 |
U2AF homology motif (UHM) kinase 1 |
|
decreases expression |
ISO |
13 |
86,010,861 |
86,025,965 |
RGD:6480464 |
CTD |
| G |
Unc93b1 |
unc-93 homolog B1 (C. elegans) |
|
increases expression |
ISO |
1 |
206,460,302 |
206,471,239 |
RGD:6480464 |
CTD |
| G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein I |
|
increases expression |
ISO |
8 |
113,955,930 |
113,967,675 |
RGD:6480464 |
CTD |
| G |
Uqcrq |
ubiquinol-cytochrome c reductase, complex III subunit VII |
|
increases expression |
EXP |
10 |
38,889,265 |
38,892,552 |
RGD:6480464 |
CTD |
| G |
Usf1 |
upstream transcription factor 1 |
|
decreases expression |
ISO |
13 |
87,336,705 |
87,344,466 |
RGD:6480464 |
CTD |
| G |
Usf2 |
upstream transcription factor 2, c-fos interacting |
|
increases expression |
ISO |
1 |
85,981,897 |
85,993,346 |
RGD:6480464 |
CTD |
| G |
Usp40 |
ubiquitin specific peptidase 40 |
|
increases expression |
ISO |
9 |
86,897,870 |
86,968,850 |
RGD:6480464 |
CTD |
| G |
Usp42 |
ubiquitin specific peptidase 42 |
|
increases expression |
ISO |
12 |
11,151,534 |
11,170,068 |
RGD:6480464 |
CTD |
| G |
Uspl1 |
ubiquitin specific peptidase like 1 |
|
decreases expression |
ISO |
12 |
6,318,581 |
6,345,858 |
RGD:6480464 |
CTD |
| G |
Uxs1 |
UDP-glucuronate decarboxylase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Vamp2 |
vesicle-associated membrane protein 2 |
|
multiple interactions |
EXP |
10 |
55,848,264 |
55,852,132 |
RGD:6480464 |
CTD |
| G |
Vamp2 |
vesicle-associated membrane protein 2 |
|
decreases expression |
EXP |
10 |
55,848,264 |
55,852,132 |
RGD:6480464 |
CTD |
| G |
Vapa |
VAMP (vesicle-associated membrane protein)-associated protein A |
|
decreases expression |
ISO |
9 |
104,339,039 |
104,368,908 |
RGD:6480464 |
CTD |
| G |
Vasp |
vasodilator-stimulated phosphoprotein |
|
decreases expression |
ISO |
1 |
78,621,494 |
78,636,762 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
decreases expression |
ISO |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
decreases expression |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
decreases expression |
ISO |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vps33a |
vacuolar protein sorting 33 homolog A (S. cerevisiae) |
|
increases expression |
ISO |
12 |
34,163,538 |
34,189,019 |
RGD:6480464 |
CTD |
| G |
Vps36 |
vacuolar protein sorting 36 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
16 |
74,462,427 |
74,486,889 |
RGD:6480464 |
CTD |
| G |
Vwa3b |
von Willebrand factor A domain containing 3B |
|
affects expression |
EXP |
9 |
35,962,036 |
36,125,741 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
increases expression |
EXP |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wasf2 |
WAS protein family, member 2 |
|
decreases expression |
ISO |
5 |
151,930,683 |
151,948,752 |
RGD:6480464 |
CTD |
| G |
Wdr35 |
WD repeat domain 35 |
|
increases expression |
ISO |
6 |
32,522,578 |
32,523,842 |
RGD:6480464 |
CTD |
| G |
Wfdc18 |
WAP four-disulfide core domain 18 |
|
increases expression |
ISO |
10 |
71,930,940 |
71,933,083 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
|
multiple interactions |
ISO |
7 |
137,557,836 |
137,561,883 |
RGD:6480464 |
CTD |
| G |
Wnt2 |
wingless-type MMTV integration site family member 2 |
|
multiple interactions |
ISO |
4 |
43,649,783 |
43,689,596 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
increases expression |
EXP |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
|
decreases expression |
ISO |
10 |
45,613,668 |
45,641,488 |
RGD:6480464 |
CTD |
| G |
Wwp1 |
WW domain containing E3 ubiquitin protein ligase 1 |
|
increases expression |
ISO |
5 |
34,238,505 |
34,325,951 |
RGD:6480464 |
CTD |
| G |
Yars |
tyrosyl-tRNA synthetase |
|
increases expression |
EXP |
5 |
148,350,363 |
148,378,989 |
RGD:6480464 |
CTD |
| G |
Yif1a |
Yip1 interacting factor homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
207,711,277 |
207,715,338 |
RGD:6480464 |
CTD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
decreases expression |
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:6480464 |
CTD |
| G |
Zbtb32 |
zinc finger and BTB domain containing 32 |
|
increases expression |
ISO |
1 |
85,635,284 |
85,637,589 |
RGD:6480464 |
CTD |
| G |
Zcchc2 |
zinc finger, CCHC domain containing 2 |
|
increases expression |
ISO |
13 |
12,148,072 |
12,196,570 |
RGD:6480464 |
CTD |
| G |
Zcchc8 |
zinc finger, CCHC domain containing 8 |
|
decreases expression |
ISO |
12 |
34,007,470 |
34,029,866 |
RGD:6480464 |
CTD |
| G |
Zfand6 |
zinc finger, AN1-type domain 6 |
|
increases expression |
ISO |
1 |
140,885,701 |
140,960,486 |
RGD:6480464 |
CTD |
| G |
Zfp263 |
zinc finger protein 263 |
|
increases expression |
ISO |
10 |
12,036,798 |
12,043,605 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
increases expression |
ISO |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
|
increases expression |
ISO |
6 |
7,530,948 |
7,534,988 |
RGD:6480464 |
CTD |
| G |
Zfp426 |
zinc finger protein 426 |
|
increases expression |
ISO |
8 |
19,472,954 |
19,505,721 |
RGD:6480464 |
CTD |
| G |
Zfyve20 |
zinc finger, FYVE domain containing 20 |
|
decreases expression |
ISO |
4 |
126,366,759 |
126,395,365 |
RGD:6480464 |
CTD |
| G |
Zmynd10 |
zinc finger, MYND-type containing 10 |
|
affects expression |
EXP |
8 |
112,794,227 |
112,798,585 |
RGD:6480464 |
CTD |
Term paths to the root
|